Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli
- PMID: 39271999
- PMCID: PMC11401301
- DOI: 10.1186/s12866-024-03472-5
Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli
Abstract
Background: In the present study, we aimed to determine the frequency of the csgA, fimH, mrkD, foc, papaGI, papGII and papGIII genes, to provide and to design fimbrial adhesin gene (FAG) patterns and profiles for the isolated uropathogenic Escherichia coli (UPEC) strains.
Methods: The enrollment of 108 positive urine samples was performed during seven months, between January 2022 and July 2022. The UPEC strains were confirmed through the standard microbiological and biochemical tests. The antimicrobial susceptibility test was performed through the Kirby-Bauer disc diffusion method. Molecular screening of FAGs was done through the polymerase chain reaction technology. The statistical analyses including chi square and Fisher's exact tests were performed to interpret the obtained results in the present study.
Results: As the main results, the antimicrobial resistance (AMR) patterns, multi- (MDR) and extensively drug-resistance (XDR) patterns and FAG patterns were designed and provided. fimH (93.3%), csgA (90.4%) and papG (37.5%) (papGII (30.8%)) genes were recognized as the top three FAGs, respectively. Moreover, the frequency of csgA-fimH gene profile was identified as the top FAG pattern (46.2%) among the others. The isolates bearing csgA-fimH gene profile were armed with a versatile of phenotypic AMR patterns. In the current study, 27.8%, 69.4% and 1.9% of the UPEC isolates were detected as extended-spectrum ß-lactamases (ESBLs) producers, MDR and XDR strains, respectively.
Conclusions: In conclusion, detection, providing and designing of patterns and profiles in association with FAGs, AMR feature in UPEC strains give us an effective option to have a successful and influential prevention for both of UTIs initiation and AMR feature.
Keywords: Antimicrobial drug resistance; Extensively drug resistance; Fimbrial adhesins; Multidrug resistance; Urinary tract infections; Uropathogenic Escherichia coli; Virulence genes.
© 2024. The Author(s).
Conflict of interest statement
Payam BEHZADI is the BMC Microbiology Editorial Board Member.
Figures

Similar articles
-
Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.J Infect Dev Ctries. 2024 May 30;18(5):761-769. doi: 10.3855/jidc.18566. J Infect Dev Ctries. 2024. PMID: 38865401
-
Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.Front Cell Infect Microbiol. 2016 Oct 31;6:135. doi: 10.3389/fcimb.2016.00135. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 27843814 Free PMC article.
-
Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic Escherichia coli isolates in relation to the antimicrobial resistance.Afr Health Sci. 2020 Mar;20(1):238-247. doi: 10.4314/ahs.v20i1.29. Afr Health Sci. 2020. PMID: 33402912 Free PMC article.
-
Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs).Folia Microbiol (Praha). 2020 Feb;65(1):45-65. doi: 10.1007/s12223-019-00719-x. Epub 2019 Jun 5. Folia Microbiol (Praha). 2020. PMID: 31165977 Review.
-
Structural and functional characterization of the FimH adhesin of uropathogenic Escherichia coli and its novel applications.Microb Pathog. 2021 Dec;161(Pt B):105288. doi: 10.1016/j.micpath.2021.105288. Epub 2021 Nov 12. Microb Pathog. 2021. PMID: 34780972 Review.
Cited by
-
Mechanisms of fluoroquinolone resistance among Escherichia coli isolates from urinary tract infections in Thailand.PLoS One. 2025 May 30;20(5):e0325175. doi: 10.1371/journal.pone.0325175. eCollection 2025. PLoS One. 2025. PMID: 40445988 Free PMC article.
-
Exploring phenotypic and genotypic diversity among methicillin-resistant, vancomycin-resistant, and sensitive Staphylococcus aureus.Medicine (Baltimore). 2024 Dec 27;103(52):e41051. doi: 10.1097/MD.0000000000041051. Medicine (Baltimore). 2024. PMID: 39969287 Free PMC article.
References
-
- Vollset, S.E.; Ababneh, H.S.; Abate, Y.H.; Abbafati, C.; Abbasgholizadeh, R.; Abbasian, M.; Abbastabar, H.; Abd Al Magied, A.H.; Abd ElHafeez, S.; Abdelkader, A. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403:2204–2256. - PMC - PubMed
-
- Behzadi, P., Behzadi, E. The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, Iran. Turk Klin Tip Bilim. 2008;28:445–449.
-
- Yazdansetad S, Alkhudhairy MK, Najafpour R, Farajtabrizi E, Al-Mosawi RM, Saki M, Jafarzadeh E, Izadpour F, Ameri A. Preliminary survey of extended-spectrum β-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran. Heliyon. 2019;5(9):e02349. 10.1016/j.heliyon.2019.e02349. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials